среда, 22 декабря 2010 г.

FDA Warns Consumers to Avoid Man Up Now Capsules

The U.S. Food and Drug Administration (FDA) is warning consumers that Man Up Now capsules may dangerously lower blood pressure.

Man Up Now is marketed as a dietary supplement for sexual enhancement, but has been found to contain sulfoaildenafil, a chemical similar to sildenafil, the active ingredient in Viagra and can dangerously lower blood pressure.
Consumers may mistakenly assume Man Up Now is harmless as it claims to be “herbal” and “all natural.” Consumers who have Man Up Now capsules should stop using them immediately.
Images: 7 reasons causing sexual problems
Sulfoaildenafil, like sildenafil, may interact with prescription drugs such as nitrates, including nitroglycerin, and cause dangerously low blood pressure. When blood pressure drops suddenly, the brain is deprived of an adequate blood supply that can lead to dizziness or lightheadedness.
Man Up Now, distributed by Synergy Distribution LLC, is sold on Internet sites, online marketplaces, and possibly in retail outlets in single, double, and triple blister packs, and in six-, 12-, and 30-count capsule bottles.
To date, the FDA is not aware of any adverse events associated with the use of the product. However, sexual enhancement products that claim to work as well as prescription products, but that contain prescription strength drugs, are likely to expose unknowing consumers to unpredictable risks and the potential for injury or death.
The FDA advises consumers who have experienced any negative side effects from sexual enhancement products to consult a health care professional and to safely discard the product. Consumers and health care professionals should report adverse events to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax:
Complete and submit the report online: www.fda.gov/MedWatch/report.htm
Download form or call 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form or submit by fax to 800-FDA-0178.
For more information:

Комментариев нет:

Отправить комментарий